Atai Life Sciences raised €105M in a Series C round in Nov 2020. The company is based in Munich, Germany. Data as of 6 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
